FIELD: organic chemistry, pharmacy.
SUBSTANCE: invention relates to substituted derivatives of propanolamine with bile acids of the formula (I):
and their pharmaceutically acceptable salts and physiologically functional derivatives wherein GS means group of bile acid of the formula (II):
wherein R1 means a bond with X, hydroxyl (OH); R2 means a bond, hydroxyl (OH), -O-(C1-C6)-alkyl, -NH-(C2-C6)-alkyl-SO3H, -NH-(C1-C6)-alkyl-COOH; R1 and R2 don't mean a bond with X simultaneously; X means
l, m, n = 0, 1; L means (C1-C6)-alkyl; AA1 and AA2 means amino acid residue independently that can be substituted once or multiple with amino-group. Compounds of the formula (I) can be used as hypolipidemic agents.
EFFECT: valuable medicinal properties of compounds.
9 cl, 4 sch, 1 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF PROPANOLAMINE, METHODS OF THEIR SYNTHESIS AND AGENT BASED ON THEREOF | 1998 |
|
RU2198876C2 |
| BILE ACID-SUBSTITUTED PHENYLALKENOYLGUANIDINES, MEDICINAL AGENT | 1999 |
|
RU2232769C2 |
| NOVEL AROMATIC FLUOROGLYCOSIDE DERIVATIVES, MEDICATIONS, CONTAINING SAID COMPOUNDS AND THEIR APPLICATION | 2003 |
|
RU2340622C2 |
| NEW HETEROCYCLIC FLUORGLUCOSIDE DERIVATIVES, MEDICATIONS CONTAINING THESE COMPOUNDS, AND THEIR APPLICATION | 2003 |
|
RU2339641C2 |
| ENDOTHELIN RECEPTOR ANTAGONISTS | 1994 |
|
RU2126418C1 |
| BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS FOR USE THEREOF | 2015 |
|
RU2707280C2 |
| PHTHALIMIDO-DERIVATIVES AS MONOAMINE OXIDASE B INHIBITORS | 2003 |
|
RU2317289C2 |
| BENZIMIDAZOLE DERIVATIVES AS SELECTIVE ACID PUMP INHIBITORS | 2007 |
|
RU2412188C2 |
| ANTIVIRAL SUBSTRATE ISOSTER ESTERS OF ASPARTATE PROTEASE OR THEIR SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL PREPARATION AND COMPOSITION | 1995 |
|
RU2164229C2 |
| DERIVATIVE OF 6-OXO-1,6-DIHYDROPYRIDAZINE, METHOD FOR PRODUCTION THEREOF AND APPLICATION THEREOF IN MEDICINE | 2020 |
|
RU2791534C2 |
